About Trellis Bioscience

Backed by NIH grant funding and venture capital, and led by an ex-pharma, serial entrepreneur management team, Trellis Bioscience (www.trellisbio.com) utilizes its CellSpot platform to discover rare, naturally optimized antibodies in healthy donor blood against infectious diseases and cancer.